HRT Financial’s Livent Corporation LTHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,979,779
Closed -$35.6M 3371
2023
Q4
$35.6M Buy
1,979,779
+1,661,911
+523% +$25.9M 0.26% 37
2023
Q3
$5.85M Buy
317,868
+143,033
+82% +$3.27M 0.06% 244
2023
Q2
$4.79M Buy
+174,835
New +$4.19M 0.04% 299
2023
Q1
Sell
-42,073
Closed -$835K 3411
2022
Q4
$835K Buy
+42,073
New +$1.15M 0.01% 1070
2022
Q3
Sell
-24,316
Closed -$551K 3709
2022
Q2
$551K Sell
24,316
-69,381
-74% -$1.79M 0.01% 1412
2022
Q1
$2.44M Buy
+93,697
New +$2.18M 0.02% 552
2021
Q4
Sell
-41,588
Closed -$961K 4326
2021
Q3
$961K Buy
41,588
+15,100
+57% +$339K 0.01% 1365
2021
Q2
$512K Buy
26,488
+14,716
+125% +$268K ﹤0.01% 1750
2021
Q1
$203K Sell
11,772
-136,908
-92% -$2.69M ﹤0.01% 2304
2020
Q4
$2.8M Buy
+148,680
New +$2.07M 0.06% 250
2019
Q4
Sell
-15,836
Closed -$105K 1778
2019
Q3
$105K Buy
+15,836
New +$106K 0.01% 1244

Other funds holding LTHM

HRT Financial's LTHM Position: Q1 2024 in Review

HRT Financial sold out of Livent Corporation (LTHM) in Q1 2024, closing a stake of 1,979,779 shares — an estimated $35.6M sold.

HRT Financial first reported a position in LTHM in Q3 2019 and held it in 11 quarters. The position peaked at $35.6M in Q4 2023. 6 funds tracked by Wall St. Rank hold LTHM as of Q1 2024.

  • HRT Financial reported no remaining Livent Corporation position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 1,979,779 Livent Corporation shares in Q1 2024, an estimated $35.6M.
  • HRT Financial first reported a position in Livent Corporation in Q3 2019 and held it in 11 quarters.
  • HRT Financial's Livent Corporation position peaked at $35.6M in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Livent Corporation as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.